1. Home
  2. CMPS vs NAMM Comparison

CMPS vs NAMM Comparison

Compare CMPS & NAMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • NAMM
  • Stock Information
  • Founded
  • CMPS 2020
  • NAMM 2024
  • Country
  • CMPS United Kingdom
  • NAMM Cayman Islands
  • Employees
  • CMPS 166
  • NAMM N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • NAMM
  • Sector
  • CMPS Health Care
  • NAMM
  • Exchange
  • CMPS Nasdaq
  • NAMM Nasdaq
  • Market Cap
  • CMPS 502.7M
  • NAMM 410.8M
  • IPO Year
  • CMPS 2020
  • NAMM N/A
  • Fundamental
  • Price
  • CMPS $5.20
  • NAMM $3.15
  • Analyst Decision
  • CMPS Strong Buy
  • NAMM
  • Analyst Count
  • CMPS 7
  • NAMM 0
  • Target Price
  • CMPS $17.00
  • NAMM N/A
  • AVG Volume (30 Days)
  • CMPS 1.8M
  • NAMM 366.4K
  • Earning Date
  • CMPS 10-30-2025
  • NAMM 01-01-0001
  • Dividend Yield
  • CMPS N/A
  • NAMM N/A
  • EPS Growth
  • CMPS N/A
  • NAMM N/A
  • EPS
  • CMPS N/A
  • NAMM N/A
  • Revenue
  • CMPS N/A
  • NAMM N/A
  • Revenue This Year
  • CMPS N/A
  • NAMM N/A
  • Revenue Next Year
  • CMPS N/A
  • NAMM N/A
  • P/E Ratio
  • CMPS N/A
  • NAMM N/A
  • Revenue Growth
  • CMPS N/A
  • NAMM N/A
  • 52 Week Low
  • CMPS $2.25
  • NAMM $2.56
  • 52 Week High
  • CMPS $7.53
  • NAMM $55.00
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 63.09
  • NAMM N/A
  • Support Level
  • CMPS $5.01
  • NAMM N/A
  • Resistance Level
  • CMPS $5.33
  • NAMM N/A
  • Average True Range (ATR)
  • CMPS 0.32
  • NAMM 0.00
  • MACD
  • CMPS 0.04
  • NAMM 0.00
  • Stochastic Oscillator
  • CMPS 81.63
  • NAMM 0.00

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About NAMM Namib Minerals Ordinary Shares

Namib Minerals is a gold producer, developer and explorer with operations focused in Zimbabwe.

Share on Social Networks: